XSDR.DE
Xtrackers MSCI Europe Health Care Screened UCITS ETF 1C
Europe
EQUITY
Rules-Based
MANAGEMENT STYLE
€ 283.8 M
ASSETS UNDER MGMT
17 bp
EXPENSES
Fund Basics
| Inception date | Jun 26, 2007 |
| Regulation | UCITS |
| Fund Website | link... |
| Distributions | |
| Currency | EUR |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ROCHE HOLDING AG-GENUSSCHEIN | 18.4 % |
| ROCHE HOLDING LTD | 18.4 % |
| ASTRAZENECA PLC | 17.7 % |
| NOVARTIS AG-REG | 16.5 % |
| NOVARTIS AG | 16.5 % |
| NOVO NORDISK A/S-B | 11.1 % |
| SANOFI-AVENTIS | 6.4 % |
| ESSILOR INTERNATIONAL | 6.0 % |
| ARGEN-X SE | 3.0 % |
| LONZA GROUP AG-REG | 3.0 % |
Constituent Breakdown
| Number of holdings | 29 |
| Herfindahl-Hirschman Index | 1,773 |
| Wgt avg mkt cap (mns) | $192,072 |
| Large cap (>$10bn) | 96.8% |
| Mid cap ($2-10bn) | 0.8% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 132.4% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
SWITZERLAND | 77.6 % |
 |
BRITAIN | 20.3 % |
 |
FRANCE | 13.5 % |
 |
DENMARK | 13.0 % |
 |
NETHERLANDS | 3.0 % |
 |
BELGIUM | 2.3 % |
 |
LUXEMBOURG | 0.6 % |
 |
FINLAND | 0.5 % |
Historical Performance
Standardized Performance (as of 04/05/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -- | -- | -- | -- | -- | -- | -- | -- |
| Dividend Yield | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Returns | -- | -- | -- | -- | -- | -- | -- | -- | Ann. Volatility | -- | -- | -- | -- | -- | -- | -- | -- |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $0.00 |
| Relative strength (RSI) | 0 |
| MACD/Signal | 0.00/0.00 |
| Bollinger Bands (Upper/Lower) | $0.00/$0.00 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XSDR.DE |
Expenses vs. XSDR.DE |
ALTAR Score™ vs. XSDR.DE |
|---|---|---|---|---|
| XSMI.DE | Xtrackers Switzerland UCITS ETF 1D | 70.8% | +13 bp | -0.4% |
| XSMC.SW | Xtrackers Switzerland UCITS ETF 1C | 68.6% | +13 bp | -0.4% |
| ESIH.L | iShares MSCI Europe Health Care Sector UCITS ETF | 66.8% | +1 bp | +0.1% |
| EXV4.DE | iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 64.9% | +29 bp | -0.2% |
| XSLI.DE | Xtrackers SLI UCITS ETF 1D | 44.4% | +8 bp | -0.5% |
| XZEC.DE | Xtrackers Stoxx European Market Leaders UCITS ETF 1C | 34.5% | +8 bp | -0.2% |
| XDWH.DE | Xtrackers MSCI World Health Care UCITS ETF 1C | 26.5% | +8 bp | -0.1% |
| XZDE.DE | Xtrackers MSCI Europe High Dividend Yield ESG UCITS ETF 1D | 26.0% | +8 bp | +1.2% |
| WHCA.L | iShares MSCI World Health Care Sector Advanced UCITS ETF | 20.1% | +1 bp | -0.5% |
| WHCS.AS | iShares MSCI World Health Care Sector Advanced UCITS ETF | 20.1% | +1 bp | -0.2% |
Risk and Returns: XSDR.DE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (EUR)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.8%
ALTAR SCORE™
39th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 239 funds in the Europe Equity category with an average
ALTAR Score™ of 7.2% and a standard deviation
of 1.3%. XSDR.DE's ALTAR Score™ is approximately -0.3 standard
deviations above the category average. This places XSDR.DE in the 39th percentile
among funds in the category.
Sell-Side Consensus
€246.58
PRICE TARGET
+5.3%
UPSIDE